Spandidos Publications style
Becker JC, Müller-Tidow C, Stolte M, Fujimori T, Tidow N, Ilea AM, Brandts C, Tickenbrock L, Serve H, Berdel WE, Berdel WE, et al: Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer. Int J Oncol 29: 615-623, 2006.
APA
Becker, J.C., Müller-Tidow, C., Stolte, M., Fujimori, T., Tidow, N., Ilea, A.M. ... Pohle, T. (2006). Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer. International Journal of Oncology, 29, 615-623. https://doi.org/10.3892/ijo.29.3.615
MLA
Becker, J. C., Müller-Tidow, C., Stolte, M., Fujimori, T., Tidow, N., Ilea, A. M., Brandts, C., Tickenbrock, L., Serve, H., Berdel, W. E., Domschke, W., Pohle, T."Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer". International Journal of Oncology 29.3 (2006): 615-623.
Chicago
Becker, J. C., Müller-Tidow, C., Stolte, M., Fujimori, T., Tidow, N., Ilea, A. M., Brandts, C., Tickenbrock, L., Serve, H., Berdel, W. E., Domschke, W., Pohle, T."Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer". International Journal of Oncology 29, no. 3 (2006): 615-623. https://doi.org/10.3892/ijo.29.3.615
